Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2023-01-17 Director's Dealing
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Form 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. Form 8.3 is a mandatory disclosure required under the UK Takeover Code when a person holding interests of 1% or more in the relevant securities of an offeror or offeree makes a dealing or holds an opening position during an offer period. This type of disclosure relates directly to insider dealings or significant position changes during a takeover scenario. This specific filing concerns 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE'. While it involves director/insider activity (similar to DIRS), the context of the Takeover Code (Rule 8.3) and the nature of the disclosure (position/dealing during an offer) makes it a specialized filing. None of the provided codes perfectly match 'Takeover Disclosure Form 8.3'. However, 'Director's Dealing (DIRS)' covers personal share transactions by executives, and this is a mandatory disclosure of interests/dealings related to an offer. Given the options, 'DIRS' is the closest fit for reporting executive/insider transactions, although 'RNS' (Regulatory Filings) is a strong fallback. Since this is a specific regulatory filing concerning interests/dealings in securities, and 'DIRS' covers director dealings, I will classify it as DIRS, as it is a specific type of insider transaction disclosure, even if the context is a takeover.
2023-01-17 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder dealings during a takeover/merger event. While it involves dealings, the specific context of the Takeover Code (Rule 8.3) points towards disclosures related to M&A activity or significant shareholding changes during a bid. Since the definitions provided include 'M&A Activity (Code: TAR)' for merger proposals or takeover bids, and 'Director's Dealing (Code: DIRS)' for personal share transactions by directors, this document, which details the position and dealings of a major shareholder (Millennium International Management LP) in relation to an offeree (Mediclinic International plc) under the Takeover Code, fits best under the umbrella of M&A Activity (TAR) as it is directly triggered by the takeover context. It is not a general Director's Dealing report (DIRS) as it is specifically tied to the Takeover Code rules regarding an offer.
2023-01-16 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of filing relates to insider transactions or significant ownership changes during a takeover/merger event. Among the provided codes, 'TAR' (M&A Activity) is the most appropriate category as it covers takeover bids and related disclosures, although 'DIRS' (Director's Dealing) is related to insider transactions, Form 8.3 is specifically mandated by the Takeover Code during M&A activity. Given the context of the Takeover Code and disclosure related to an offeror/offeree, TAR is the best fit, as it encompasses the regulatory environment triggering this specific disclosure.
2023-01-13 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled "FORM 8.3 - Mediclinic International plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interest in relevant securities during a takeover situation. This type of disclosure relates to insider transactions or significant ownership changes during a takeover/merger event. Among the provided categories, 'M&A Activity' (TAR) is the closest fit as it covers merger proposals or takeover bids, and this filing is a direct consequence of such an event (a takeover bid for Mediclinic International plc). It is not a general Director's Dealing (DIRS) as it is specifically tied to the Takeover Code rules during an offer period.
2023-01-12 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates directly to insider transactions or significant ownership changes during a takeover or merger scenario. Among the provided categories, 'Director's Dealing (Code: DIRS)' covers personal share transactions by executives, and 'M&A Activity (Code: TAR)' covers takeover bids. Since this specific form (Form 8.3) is mandated by the UK Takeover Code and details interests/dealings related to an offer (Mediclinic International plc), it is most closely aligned with disclosures related to M&A activity or insider dealings during a bid. Given the context of the Takeover Code, it is a specific type of insider disclosure related to a potential takeover. While DIRS covers general insider trades, this is highly specific to a takeover situation. However, the core content is about the 'Interests and short positions' and 'Dealings' of a major shareholder (Millennium International Management LP) in relation to an offer. This strongly suggests it falls under the scope of M&A Activity (TAR) or Director's Dealing (DIRS). Since Form 8.3 is a mandatory disclosure during a takeover/offer period, TAR is a strong candidate. However, DIRS is for director/executive trades, and while this is a major shareholder, the context is the takeover. Let's re-evaluate the definitions. None of the definitions perfectly match 'Form 8.3 Disclosure'. Form 8.3 is a specific regulatory filing under the Takeover Code. Given the options, 'M&A Activity (TAR)' is the best fit because Form 8.3 is triggered by an offer/takeover situation. If TAR is too broad, DIRS is for director dealings, which this is not strictly, although it is insider-like. Given the explicit reference to the Takeover Code and the nature of the disclosure (position disclosure during an offer), TAR is the most appropriate classification for filings related to takeover activity.
2023-01-11 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder activity during a takeover bid, which falls under the scope of M&A activity or specific regulatory filings related to takeovers. Since the definitions provided do not have a specific code for 'Takeover Disclosure Form 8.3', the most appropriate classification is related to M&A Activity (TAR) or the general Regulatory Filings (RNS). Given the context is explicitly about a takeover ('Takeover Code', 'offeror/offeree'), TAR (M&A Activity) is the most specific fit, as these disclosures are mandatory during such events. If TAR were not available, RNS would be the fallback. I will classify it as TAR due to the direct reference to the Takeover Code and the context of an offer.
2023-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.